Методы топической диагностики АКТГ-продуцирующих нейроэндокринных опухолей различной локализации (обзор литературы)
https://doi.org/10.14341/2306-3513-2012-4-4-10
Аннотация
Список литературы
1. Newell-Price J., Bertagna X., Grossman A.B. et al. Cushing’s syndrome. Lancet. 2006; 367: 1605–1617.
2. Aniszewski J.P., Young W.F., Thompson G.B. et al. Cushing syndrome due to ectopic adrenocorticotropic hormone secretion. Wld J. Surg. 2001; 25: 934–940.
3. Ilias I., Torpy D.J., Pacak K., Mullen N. et al. Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. J. Clin. Endocrinol. Metab. 2005; 90: 4955–4962.
4. Scully R.E., Mark E.J., McNneely W.F. Case 4-2000. The New Engl. J. Med. 2000; 10: 414–420.
5. Rosch T., Lightdale C.J., Botet J.F. et al. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N. Engl. J. Med. 1992; 326: 1721–1726.
6. Javorsky B.R., Carroll T.B., Findling J.W. Differential Diagnosis of Cushing’s Syndrome. New York: Springer, 2011: 85–107.
7. Sahdev A., Rodney H., Reznek J. et al. Imaging in Cushing’s syndrome. Arq. Bras. Endocrinol. Metab. 2007; 51/8: 1319–1328.
8. Horton K.M., Kamel I., Hofmann L. et al. Carcinoid tumors of the small bowel: a multitechnique imaging approach. Am. J. Roentgenol. 2004; 182: 559–567.
9. Isidori A.M., Kaltsas G.A., Pozza C. et al. The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J. Clin. Endocrinol. Metab. 2006; 91: 371–377.
10. Krakoff J., Koch C.A., Calis K.A. et al. Use of a parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing' s syndrome. J. Clin. Endocrinol. Metab. 2001; 86: 4104–4108.
11. Fasshauer M., Lincke T., Witzigmann H. et al. Ectopic Cushing' syndrome caused by a neuroendocrine carcinoma of the mesentery. BMC Cancer 2006; 6: 108.
12. Beuschlein F., Hammer G.D. Ectopic pro-opiomelanocortin syndrome. Endocrinol. Metab. Clin. North Am. 2002; 31: 191–234.
13. Tsagarakis S., Christoforaki M., Giannopoulou H. et al. A reappraisal of the utility of somatostain receptor scintigraphy in patients with ectopic adrenocorticotropin Cushing’s syndrome. J. Clin. Endocrinol. Metab. 2003; 88: 4754–4747.
14. Pacak K., Ilias I., Chen C.C. et al. The role of [18F]fluorodeoxyglucose positron emission tomography and [111In]diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropinsecreting tumors causing Cushing’s syndrome. J. Clin. Endocrinol. Metab. 2004; 89: 2214–2221.
15. Waintrop C., Tenenbaum F., Coulot J. et al. Image in endocrinology: localization of an occult adrenocorticotropinsecreting carcinoid tumor with somatostatin receptor scintigraphy using single-photon emission computed tomography/computed tomographic image scanning. J. Clin. Endocrinol. Metab. 2006; 91: 3271–3272.
16. Sookur P.A., Sahdev A., Rockall A.G. et al. Imaging in covert ectopic ACTH secretion: a CT pictorial review. Eur. Radiol. 2009; 19: 1069–1078.
17. Shrager J.B., Wright C.D., Wain J.C. et al. Bronchopulmonary carcinoid tumors associated with Cushing's syndrome: a more aggressive variant of typical carcinoid. J. Thorac. Cardiovasc. Surg. 1997; 114: 367–375.
18. Torpy D.J., Chen C.C., Mullen N. et al. Lack of utility of (111)In-pentetreotide scintigraphy in localizing ectopic ACTH producing tumors: follow-up of 18 patients. J. Clin. Endocrinol. Metab. 1999; 84: 1186–1192.
19. Castellani M., Ambrosi B. Difficulties in diagnosis and treatment of ectopic ACTH-producing tumors of the chest. Eur. J. Cardiothorac. Surg. 2002; 21: 149–151.
20. Sundin A., Garske U., Orlefors H. Nuclear imaging of neuroendocrine tumours. Best Practice & Research Clinical Endocrinology & Metabolism 2007; 21: 69–85.
21. Kaltsas G., Korbonits M., Heintz E. et al. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J. Clin. Endocrinol. Metab. 2001; 86: 895–902.
22. Van der Harst E., De Herder W.W., Bruining H.A. et al. [123I]Metaiodobenzylguanidine and [111In]Octreotide uptake in benign and malignant pheochromocytomas. J. Clin. Endocrinol. Metab. 2001; 86: 685–693.
23. De Herder W.W., Lamberts S.W. Octapeptide somatostatinanalogue therapy of Cushing's syndrome. Postgrad. Med. J. 1999; 75: 65–66.
24. Xu H., Zhang M., Zhai G. et al. The role of integrated 18F-FDG PET/CT in identification of ectopic ACTH secretion tumors. Endocrinology. 2009; 36: 385–391.
25. Zemskova M.S., Gundabolu B., Sinaii N. et al. Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors. J. Clin. Endocrinol. Metab. 2010; 95: 1207–1219.
26. De Perrot M., Spiliopoulos A., Fischer S. et al. Neuroendocrine carcinoma (carcinoid) of the thymus associated with Cushing’s syndrome. Ann. Thorac. Surg. 2002; 73: 675–681.
27. Rufini V., Calcagni M.L., Baum R.P. Imaging of neuroendocrine tumors. Semin. Nucl. Med. 2006; 36: 228–247.
Рецензия
Для цитирования:
., ., . Методы топической диагностики АКТГ-продуцирующих нейроэндокринных опухолей различной локализации (обзор литературы). Эндокринная хирургия. 2012;6(4):4-10. https://doi.org/10.14341/2306-3513-2012-4-4-10
For citation:
Latkina N.V., Dobreva E.A., Kuznetsov N.S. Methods of topical diagnosis of ectopic ACTH-producing tumors of different localization (review of the literature). Endocrine Surgery. 2012;6(4):4-10. (In Russ.) https://doi.org/10.14341/2306-3513-2012-4-4-10

Контент доступен под лицензией Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).